close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

25.31 +0.27 (+1.08%)
Streaming Delayed Price Updated: 10:53 AM EST, Dec 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Down 80%, Should You Buy the Dip on Moderna? ↗
Your decision on whether to invest now depends to some extent on your investment strategy. 
Via The Motley Fool
News headline image
1 S&P 500 Stock with Impressive Fundamentals and 2 That Underwhelm
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural... 
Via StockStory
Topics Stocks
News headline image
3 Absurdly Cheap Stocks You Can Buy For Less than $100 Right Now ↗
The stocks listed here trade at forward earnings multiples of less than 18. 
Via The Motley Fool
News headline image
Better Buy in 2026: Pfizer or Eli Lilly? ↗
These two stocks have been going in opposite directions over the past few years. 
Via The Motley Fool
Topics World Trade
News headline image
Flying Blind: How the Record 43-Day Shutdown Blinded the Fed and Rattled Global Markets
The United States economy is finally emerging from a period of unprecedented statistical darkness. Following the conclusion of the longest government shutdown in American history—a 43-day impasse that... 
Via MarketMinute
Topics Artificial Intelligence Bonds Credit Cards
News headline image
The Weight of a Trillion: Inside Eli Lilly’s Pharmaceutical Hegemony
On this day in late 2025, Eli Lilly and Company (NYSE: LLY) stands as the undisputed titan of the global pharmaceutical industry. Having crossed the historic $1 trillion market capitalization threshold... 
Via PredictStreet
Topics Economy World Trade
News headline image
Industry Comparison: Evaluating Pfizer Against Competitors In Pharmaceuticals Industry ↗
 
Via Benzinga
News headline image
Pfizer Plays Catchup In Obesity Market, Licenses Weight-loss Drug From Fosun ↗
 
Via Benzinga
News headline image
The Emotional Rollercoaster: How Fear and Greed Shape Investor Behavior in Market Downturns
The financial markets, often perceived as bastions of rational decision-making, are, in reality, deeply swayed by the powerful currents of human emotion. As the global economy navigates its inherent... 
Via MarketMinute
Topics Bonds Economy Supply Chain
News headline image
These 2 Healthcare Stocks Just Declared Dividend Raises ↗
The healthcare industry has never been a great source of dividends -- that alone makes these companies exceptional. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Novartis US Stock Rises On Reports Of White House Pricing Deal Due Friday — Roche Also In Talks ↗
The potential agreements would mark another step in Washington’s broader effort to reshape drug pricing. 
Via Stocktwits
Topics Government World Trade
News headline image
Curious about the most active S&P500 stocks in today's session? ↗
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention. 
Via Chartmill
News headline image
Moderna (MRNA) Stock Trades Up, Here Is Why
Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 4% in the afternoon session after the broader biotech sector experienced a strong rebound, lifting shares of companies within the industry. 
Via StockStory
Topics Artificial Intelligence
News headline image
If I Could Only Buy and Hold a Single Stock, This Would Be It ↗
Pfizer's shares look attractive to investors willing to show patience. 
Via The Motley Fool
Topics Intellectual Property
News headline image
FDA Approves Brain Tumor Warning For Pfizer&#39;s Depo-Provera Amid Lawsuit ↗
FDA approves a new Depo-Provera warning on meningioma risk as Pfizer faces lawsuits alleging delayed disclosure of brain tumor concerns. 
Via Benzinga
Topics Lawsuit
News headline image
Pfizer, Merck Are Boring Again — And That&#39;s Exactly Why 2026 Investors Are Circling Back ↗
Pfizer & Merck are the boring intentional reset w/flat growth expectations. Pfizer now offers high dividends, Merck offers reliability. 
Via Benzinga
News headline image
Nasdaq Navigates Choppy Waters: Tech Index Shows Resilience Amidst Volatility and AI Bubble Concerns
The Nasdaq Composite (IXIC) has been on a rollercoaster ride as 2025 draws to a close, experiencing a notable three-day losing streak before showing a modest rebound on December 17. This recent... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Dow Jones Soars to New Highs Amidst Economic Crosscurrents and AI Jitters
New York, NY – December 17, 2025 – The Dow Jones Industrial Average (DJIA) has concluded December 2025 with a notable ascent, marking a period of robust performance that has seen the index reach new... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
The Ultimate High-Yield Drug Stock to Buy With $1,000 Right Now ↗
It doesn't have the highest yield, but it has enviable dividend coverage and a long history of surviving in a competitive industry. 
Via The Motley Fool
Topics Intellectual Property
News headline image
S&P Futures Gain as Investors Weigh U.S. Jobs Data, Fed Speak and Micron Earnings in Focus
December S&P 500 E-Mini futures (ESZ25) are trending up +0.27% this morning as investors continue to digest the latest U.S. jobs data, while also awaiting remarks from Federal Reserve officials and an... 
Via Barchart.com
Topics Economy Government Stocks
News headline image
obs Data Trips the Dow While AI Legislation Keeps Nasdaq Awake ↗
A messy, shutdown-delayed jobs print pushed unemployment to a four-year high, oil slid to fresh multi-year lows, and energy stocks took the punch. Meanwhile, an AI-infrastructure permitting push in the... 
Via Chartmill
Topics Artificial Intelligence Stocks
News headline image
Tilray Brands, Pfizer, Netflix, Lennar Corp. And Tesla: Why These 5 Stocks Are On Investors&#39; Radars Today ↗
TLRY, PFE, NFLX, LEN, TSLA were among the stocks seen trending amid investors on Tuesday, Dec. 16, 2025. 
Via Benzinga
News headline image
Stock Market Today, Dec. 16: Pfizer Falls After Cutting 2025 Revenue Forecast ↗
Today, Dec. 16, 2025, Pfizer's shrinking COVID cash flows could mean little growth next year as M&A bets will take time to deliver. 
Via The Motley Fool
Topics Intellectual Property Stocks
News headline image
Discover which S&P500 stocks are making waves on Tuesday. ↗
Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
News headline image
Why Is Monte Rosa Stock Trading Higher Today? ↗
Monte Rosa reports interim Phase 1/2 data showing durable responses and manageable safety for MRT-2359 plus Pfizer's Xtandi in advanced prostate cancer patients. 
Via Benzinga
News headline image
Pfizer's Muted 2026 Outlook Sends Ripples Through Pharmaceutical Sector
New York, NY – December 16, 2025 – Pfizer Inc. (NYSE: PFE) today delivered a sobering financial outlook for 2026, projecting revenue and adjusted earnings per share (EPS) that fell short of Wall... 
Via MarketMinute
Topics Intellectual Property
News headline image
Curious about the most active stocks on Tuesday? ↗
Discover the most active stocks in Tuesday's session. Stay informed about the stocks that are generating the most trading volume! 
Via Chartmill
News headline image
1 Bold Prediction for Viking Therapeutics in 2026 ↗
Viking's pipeline may release its value next year, and larger companies are likely to consider acquiring it. 
Via The Motley Fool
News headline image
Pfizer Stock On-Track For Worst Day In Over 8 Months As BofA Flags Faster Covid-19 Product Erosion ↗
The company now expects full year 2025 guidance of about $62 billion, to the lower end of its previous guidance of $61 to $64 billion and below an analyst estimate of $62.52 billion. 
Via Stocktwits
News headline image
These S&P500 stocks are moving in today's session ↗
Stay informed about the performance of the S&P500 index in the middle of the day on Tuesday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today